Bleeding Disorders
Conference Coverage
Safety profiles of hemophilia agents vary widely
Conference Coverage
Factor VIII concentrate is here to stay in hemophilia A
From the Journals
Immunoabsorption shows promise as an adjunct treatment for high-risk acquired hemophilia
Feature
Doctors search for missing link between COVID-19 and ITP
“We don’t know much about platelet counts in COVID-19 at all.”
Guidelines
Von Willebrand disease guidelines address women’s bleeding concerns
Conference Coverage
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
Conference Coverage
A 4-point thrombocytopenia score was found able to rule out suspected HIT
From the Journals
Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A
Inhibitors occurred at an early age of 13 years with a prevalence of 2.6%, but were not associated with increased mortality.
Conference Coverage
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
Conference Coverage
No benefit from tranexamic acid prophylaxis in blood cancers
From the Journals
Hemochromatosis variants may confer 10-fold higher risk of liver cancer
Men of European ancestry had a greater risk of liver cancer and death if they had HFE variants.